{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:20:22Z","timestamp":1774261222046,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12325-019-01064-8","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T09:02:52Z","timestamp":1567846972000},"page":"3221-3237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent?"],"prefix":"10.1007","volume":"36","author":[{"given":"Antonietta","family":"Stellavato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile Francesca","family":"Restaino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Finamore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Ruosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1066-843X","authenticated-orcid":false,"given":"Chiara","family":"Schiraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,7]]},"reference":[{"issue":"11","key":"1064_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.joca.2009.04.009","volume":"17","author":"MPH Le Graverand-Gastineau","year":"2009","unstructured":"Le Graverand-Gastineau MPH. OA clinical trials: current targets and trials for OA choosing molecular targets: what have we learned and where we are headed. Osteoarthr Cartil. 2009;17(11):1393\u2013401.","journal-title":"Osteoarthr Cartil"},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","volume":"44","author":"T Wang","year":"2018","unstructured":"Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/annrheumdis-2013-204660","volume":"73","author":"PG Conaghan","year":"2014","unstructured":"Conaghan PG, Kloppenburg M, Schett G, Bijlsma JW. Osteoarthritis research priorities: a report from EULAR ad hoc expert committee. Ann Rheum Dis. 2014;73:1442\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1064_CR4","first-page":"134","volume":"1","author":"X Chevalier","year":"2017","unstructured":"Chevalier X, Conrozier T. Access to highly purified chondroitin sulfate for appropriate treatment of osteoarthritis: a review. MA@PoC. 2017;1(1):134\u201344.","journal-title":"MA@PoC"},{"issue":"3","key":"1064_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.bbrc.2018.12.030","volume":"508","author":"Z Yun","year":"2019","unstructured":"Yun Z, Peng HZ, Wang W, et al. A20 inhibits the release of inflammatory cytokines by suppressing the activation of the nuclear factor-kappa B pathway in osteoarthritic fibroblast-like synoviocytes. Biochem Biophys Res Commun. 2019;508(3):877\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.phymed.2017.10.016","volume":"38","author":"R Hong","year":"2018","unstructured":"Hong R, Sur B, Yeom M, et al. Anti-inflammatory and anti-arthritic effects of the ethanolic extract of Aralia continentalis Kitag. In IL-1\u03b2-stimulated human fibroblast-like synoviocytes and rodent models of polyarthritis and nociception. Phytomedicine. 2018;38:45\u201356.","journal-title":"Phytomedicine"},{"issue":"5","key":"1064_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","volume":"23","author":"MB Goldring","year":"2011","unstructured":"Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"1064_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11926-018-0794-5","volume":"20","author":"MH Majeed","year":"2018","unstructured":"Majeed MH, Sherazi SAA, Bacon D, Bajwa ZH. Pharmacological treatment of pain in osteoarthritis: a descriptive review. Curr Rheumatol Rep. 2018;20(12):88.","journal-title":"Curr Rheumatol Rep"},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijcpr.2017v9i2.17380","volume":"2","author":"AM Agiba","year":"2017","unstructured":"Agiba AM. Nutraceutical formulations containing glucosamine and chondroitin sulphate in the treatment of osteoarthritis: emphasis on clinical efficacy and formulation challenges. Int J Curr Pharm Res. 2017;2:1\u20137.","journal-title":"Int J Curr Pharm Res"},{"issue":"3","key":"1064_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1185\/03007995.2012.753430","volume":"29","author":"M Hochberg","year":"2013","unstructured":"Hochberg M, Chevalier X, Henrotin Y, Hunter DJ, Uebelhart D. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what\u2019s the evidence. Curr Med Res Opin. 2013;29(3):259\u201367.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"1064_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/13543784.2013.770837","volume":"22","author":"PS Davies","year":"2013","unstructured":"Davies PS, Graham SM, MacFarlane RJ, Leonidou A, Mantalaris A, Tsiridis E. Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation. Expert Opin Investig Drugs. 2013;22(4):423\u201341.","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"1064_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145\u201355.","journal-title":"Ann Rheum Dis"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/ard.2004.028886","volume":"64","author":"W Zhang","year":"2005","unstructured":"Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669\u201381.","journal-title":"Ann Rheum Dis"},{"key":"1064_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/art.20867","volume":"52","author":"BA Michel","year":"2005","unstructured":"Michel BA, Stucki G, Frey D, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52:779\u201386.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1064_CR15","first-page":"23","volume":"1","author":"N Volpi","year":"2009","unstructured":"Volpi N, Maccari F. Two analytical approaches to the evaluation of chondroitin sulfate in European food supplements. Sep Sci. 2009;1(1):23\u20138.","journal-title":"Sep Sci"},{"issue":"3","key":"1064_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12161-008-9020-9","volume":"1","author":"N Volpi","year":"2008","unstructured":"Volpi N, Maccari F. Quantitative and qualitative evaluation of chondroitin sulfate in dietary supplements. Food Anal Methods. 2008;1(3):195\u2013204.","journal-title":"Food Anal Methods"},{"issue":"10","key":"1064_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/jctb.4454","volume":"89","author":"YG Shi","year":"2014","unstructured":"Shi YG, Meng YC, Li JR, Chen J, Liu YH, Bai X. Chondroitin sulfate: extraction, purification, microbial and chemical synthesis. Chem Tech Biotechnol. 2014;89(10):1445\u201365.","journal-title":"Chem Tech Biotechnol."},{"key":"1064_CR18","doi-asserted-by":"publisher","first-page":"17049","DOI":"10.1038\/sigtrans.2017.49","volume":"2","author":"EC Collin","year":"2017","unstructured":"Collin EC, Carroll O, Kilcoyne M, Peroglio M, See W, Hendig D, Alini M, Grad S, Pandit A. Ageing affects chondroitin sulfates and their synthetic enzymes in the intervertebral disc. Signal Trans Target Ther (2017);2:17049.","journal-title":"Signal Trans Target Ther"},{"key":"1064_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","volume":"44","author":"O Bruyere","year":"2014","unstructured":"Bruyere O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:253\u201363.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1064_CR20","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.semarthrit.2017.07.002","volume":"47","author":"O Bruy\u00e8re","year":"2017","unstructured":"Bruy\u00e8re O, Cooper C, Cutolo M, Reginster JY. International endorsement of the ESCEO algorithm for management of knee osteoarthritis in clinical practice. Semin Arthritis Rheum. 2017;47(2):e10.","journal-title":"Semin Arthritis Rheum"},{"key":"1064_CR21","doi-asserted-by":"publisher","unstructured":"Bruy\u00e8re O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2019.04.008\n                    \n                  .","DOI":"10.1016\/j.semarthrit.2019.04.008"},{"key":"1064_CR22","first-page":"41","volume-title":"Chondroitin sulfate: structure, uses and health implications","author":"OF Restaino","year":"2013","unstructured":"Restaino OF, De Rosa M, Cimini D, Schiraldi C. Manufacturing chondroitin sulfate: from animal source extraction to biotechnological production. In: Pomin VH, editor. Chondroitin sulfate: structure, uses and health implications. New York: Nova Science; 2013. p. 41\u201356."},{"issue":"958","key":"1064_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.aca.2016.12.005","volume":"15","author":"OF Restaino","year":"2017","unstructured":"Restaino OF, Finamore R, Diana P, et al. A multi-analytical approach to better assess the keratan sulfate contamination in animal origin chondroitin sulfate. Anal Chim Acta. 2017;15(958):59\u201370.","journal-title":"Anal Chim Acta"},{"issue":"10","key":"1064_CR24","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/glycob\/10.10.951","volume":"10","author":"JL Funderburgh","year":"2000","unstructured":"Funderburgh JL. Keratan sulfate: structure, biosynthesis, and function. Glycobiology. 2000;10(10):951\u20138.","journal-title":"Glycobiology"},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.carbpol.2012.06.009","volume":"90","author":"VH Pomin","year":"2012","unstructured":"Pomin VH, Piquet AA, Pereira MS, Mour\u00e3o PAS. Residual keratan sulfate in chondroitin sulfate formulations for oral administration. Carbohydr Polym. 2012;90:839\u201346.","journal-title":"Carbohydr Polym"},{"issue":"1505","key":"1064_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.chroma.2017.04.045","volume":"7","author":"S Bottelli","year":"2017","unstructured":"Bottelli S, Grillo G, Barindelli E, Nencioni A, Di Maria A, Fossati T. Validated high-performance anion-exchange chromatography with pulsed amperometric detection method for the determination of residual keratan sulfate and other glucosamine impurities in sodium chondroitin sulfate. J Chromatogr A. 2017;7(1505):43\u20139.","journal-title":"J Chromatogr A"},{"key":"1064_CR27","doi-asserted-by":"crossref","unstructured":"Restaino OF, Finamore R, Stellavato A, et al. European chondroitin sulfate and glucosamine food supplements: a systematic quality and quantity assessment compared to pharmaceuticals. Carbohydr Polym. 2019;222:114984.","DOI":"10.1016\/j.carbpol.2019.114984"},{"issue":"5","key":"1064_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s12325-019-00921-w","volume":"36","author":"G Honvo","year":"2019","unstructured":"Honvo G, Bruy\u00e8re O, Geerinck A, Veronese N, Reginster JY. Efficacy of chondroitin sulfate in patients with knee osteoarthritis: a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials. Adv Ther. 2019;36(5):1085\u201399.","journal-title":"Adv Ther"},{"key":"1064_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"issue":"9","key":"1064_CR30","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/jcb.25556","volume":"117","author":"A Stellavato","year":"2016","unstructured":"Stellavato A, Tirino V, De Novellis F, et al. Biotechnological chondroitin a novel glycosaminoglycan with remarkable biological function on human primary chondrocytes. J Cell Biochem. 2016;117(9):2158\u201369.","journal-title":"J Cell Biochem"},{"issue":"4","key":"1064_CR31","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar3077","volume":"12","author":"V Calamia","year":"2010","unstructured":"Calamia V, Ruiz-Romero C, Rocha B, Fernandez-Puente P, Mateos J. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther. 2010;12(4):R138.","journal-title":"Arthritis Res Ther"},{"key":"1064_CR32","first-page":"4328219","volume":"23","author":"A Stellavato","year":"2019","unstructured":"Stellavato A, Vassallo V, La Gatta A, et al. Novel hybrid gels made of high and low molecular weight hyaluronic acid induce proliferation and reduce inflammation in an osteoarthritis in vitro model based on human synoviocytes and chondrocytes. Biomed Res Int. 2019;23:4328219.","journal-title":"Biomed Res Int"},{"key":"1064_CR33","first-page":"7","volume":"30","author":"A Stellavato","year":"2016","unstructured":"Stellavato A, de Novellis F, Reale S, De Rosa M, Schiraldi C. Hybrid complexes of high and low molecular weight: evaluation using an in vitro model of osteoarthritis. J Biol Regul Homeost Agents. 2016;30:7\u201316.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"5","key":"1064_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2460\/ajvr.78.5.579","volume":"78","author":"AH Kilborne","year":"2017","unstructured":"Kilborne AH, Hussein H, Bertone AL. Effects of hyaluronan alone or in combination with chondroitin sulfate and N-acetyl-d-glucosamine on lipopolysaccharide challenge-exposed equine fibroblast-like synovial cells. Am J Vet Res. 2017;78(5):579\u201388.","journal-title":"Am J Vet Res"},{"issue":"2","key":"1064_CR35","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3892\/mmr.2017.6691","volume":"16","author":"Y Yamagishi","year":"2017","unstructured":"Yamagishi Y, Someya A, Imai K, Nagao J, Nagaoka I. Evaluation of the anti inflammatory actions of various functional food materials including glucosamine on synovial cells. Mol Med Rep. 2017;16(2):1353\u20139.","journal-title":"Mol Med Rep"},{"issue":"9","key":"1064_CR36","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1039\/C8FO01095A","volume":"9","author":"YQ Qian","year":"2018","unstructured":"Qian YQ, Feng ZH, Li XB, et al. Downregulating PI3\u00a0K\/Akt\/NF-\u03baB signaling with allicin for ameliorating the progression of osteoarthritis: in vitro and vivo studies. Food Funct. 2018;9(9):4865\u201375.","journal-title":"Food Funct"},{"issue":"10","key":"1064_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1185\/03007995.2013.813839","volume":"29","author":"MC Hochberg","year":"2013","unstructured":"Hochberg MC, Berry S, Broglio K, et al. Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis. Curr Med Res Opin. 2013;29(10):1213\u201322.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1064_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40520-017-0861-1","volume":"30","author":"O Bruy\u00e8re","year":"2018","unstructured":"Bruy\u00e8re O, Cooper C, Al-Daghri NM, Dennison EM, Rizzoli R, Reginster JY. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res. 2018;30(2):111\u20137.","journal-title":"Aging Clin Exp Res"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01064-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:40:54Z","timestamp":1599349254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01064-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,7]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01064-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,7]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}